Resources | NITAG RESOURCE CENTER

2024 ∙ JCVI

JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination

2024 ∙ NIAC

Updated recommendations for the vaccination of adults against measles

2024 ∙ SAGE

Development of WHO immunization policy and strategic guidance

2024

Considerations to inform country COVID-19 vaccination decision-making

2024 ∙ ATAGI

ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants

2024 ∙ Louise Henaff, Dace Zavadska, Mario Melgar, Johanna Fihman, Christoph Steffen, Joachim Hombach

The role of NITAGs in government decisions on vaccine use: insights from the Fifth Global NITAG Network meeting

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2024

Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt, January 2024

2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.

A review of factors influencing vaccination policies and programs for older adults globally

2023 ∙ Xu, K. Wang, Z. Qin, M. Gao, Y. Luo, N. Xie, W. Zou, Y. Wang, J. Ma, X.

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults